Physician
General Surgery
Dr. Bijan Eghtesad, MD
|
|
Give Review
Bijan Eghtesad practices General Surgery. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Bijan Eghtesad is a published MD as well. He has 99 publications published. The latest was: Role of splenectomy in human liver transplantation under modern-day immunosuppression. Bijan Eghtesad accepts Medicare payments and is registered with Medicare.gov.
Publications
- Risk stratification of alloGraft failure secondary to hepatitis C recurrence after liver transplantation.
- Cardiovascular risk factors and cardiac disorders in long-term survivors of pediatric Liver transplantation.
- Prognostic Role of Plasma Vascular Endothelial Growth Factor in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
- Post-Liver transplantation sarcopenia in cirrhosis: a prospective evaluation.
- Ex Vivo Normothermic Machine Perfusion Is Safe, Simple, and Reliable: Results From a Large Animal Model.
- Liver Transplantation for Malignancies.
- Role of vasodilation during normothermic machine perfusion of DCD porcine Livers.
- Sequential split liver followed by isolated Intestinal transplant: the "liver-first" approach: report of a case.
- Impact of Pretransplant Rifaximin Therapy on Early Post-Liver Transplant Infections.
- The successful use of telaprevir to treat hepatitis C recurrence after Liver transplantation in an HIV co-infected patient.
- Role of tissue expanders in patients with loss of Abdominal domain awaiting intestinal transplantation.
- Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism.
- 3-dimentional (3D) print of Liver for preoperative planning in live donor Liver transplantation.
- Recurrent upper gastroIntestinal bleeding masquerading as gastric variceal bleeding on endoscopy after liver transplantation.
- Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoRegional therapies.
- Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation.
- Adenosine Increases Hepatic Artery Flow in Liver Transplant Recipients: A Pilot Study.
- Re-examination of sinusoidal deposition of complement 4d in liver alloGrafts: experience from a single institution.
- Cumulative risk of cardiovascular events after orthotopic Liver transplantation.
- Hepatic blood flow plays an important role in ischemia-reperfusion injury.
- Future prospects in Liver transplant immunosuppression.
- Duct-to-Duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation.
- Liver transplantation at Cleveland Clinic.
- Splenic artery embolization for the treatment of refractory ascites after Liver transplantation.
- Combined Liver-Kidney Transplants: Allosensitization and Recipient Outcomes.
- Spur cell anemia as a cause of unconjugated hyperbilirubinemia after Liver transplantation and its resolution after retransplantation.
- Use of tissue plasminogen activator in Liver transplantation from donation after cardiac death donors.
- Is impaired hepatic arterial buffer response a risk factor for Biliary anastomotic stricture in liver transplant recipients?
- Acetaminophen: old drug, new warnings.
- Measurement of CD4+ T-cell function in predicting alloGraft rejection and recurrent hepatitis C after liver transplantation.
- Posttransplant metabolic syndrome: an epidemic waiting to happen.
- Reversal of protein-losing enteropathy after Liver transplantation in a child with idiopathic familial neonatal hepatitis.
- The Cleveland Clinic FACES Score: a preliminary assessment tool for identifying the optimal face transplant candidate.
- Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in Liver transplant ...
- First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries.
- Sialadenosis in patients with advanced liver Disease.
- Near-total human face transplantation for a severely disfigured patient in the USA.
- Rapid resolution of GVHD after orthotopic Liver transplantation in a patient treated with alefacept.
- Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic Liver is higher when hepatoma is beyond Milan criteria.
- Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow Obstruction after liver transplanta...
- "Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not Arterial siphon.
- Cruveilhier-Baumgarten Disease in a patient with Turner syndrome: case report of a rare indication for liver transplantation.
- Association between donor-recipient serum sodium differences and orthotopic liver transplant Graft function.
- Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during Liver transplantation.
- Using Livers from donation after cardiac death donors--a proposal to protect the true Achilles heel.
- Dental health status of Liver transplant candidates.
- Liver transplantation in precirrhotic Biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal...
- Survival of Liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.
- Pulmonary hypertension after Liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature.
- Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome.
- Isolated right hepatic vein Obstruction after piggyback liver transplantation.
- Expanding the donor pool: safe transplantation of a cadaveric liver alloGraft with a 10 cm cavernous hemangioma--a case report.
- MELD and prediction of post-Liver transplantation survival.
- Extended follow-up of extended right lobe living donors: when is enough enough?
- Preservation solutions in Liver transplantation: what are the options?
- Immunosuppression for Liver transplantation in HCV-infected patients: mechanism-based principles.
- Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver Disease.
- Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following Liver transplantation.
- Technical considerations in Liver transplantation: what a hepatologist needs to know (and every surgeon should practice).
- Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.
- Tacrolimus for primary Liver transplantation: 12 to 15 years actual follow-up with safety profile.
- Livers transplanted from donors after cardiac death occurring in the ICU or the operating room have excellent outcomes.
- Immunosuppression in Liver transplantation: beyond calcineurin inhibitors.
- A survey of dental care protocols among US organ transplant centers.
- Review article: current status of Liver transplantation in HIV-infected patients.
- Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation.
- Severe hemolysis resulting from D incompatibility in a case of ABO-identical Liver transplant.
- Use of alemtuzumab and tacrolimus monotherapy for cadaveric Liver transplantation: with particular reference to hepatitis C virus.
- Liver transplantation in patients with HIV infection.
- Diagnosis and treatment of intracardiac thrombosis during orthotopic Liver transplantation.
- Recurrent hepatitis C in liver alloGrafts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.
- Lessons of organ-induced tolerance learned from historical clinical experience.
- Liver transplantation for growing teratoma syndrome: report of a case.
- Pregnancy after Liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years.
- Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in Liver transplantation patients.
- Four-color flow cytometric analysis of Peripheral blood donor cell chimerism.
- Tolerogenic immunosuppression for organ transplantation.
- Dental management of the (solid) organ transplant patient.
- Living donor Liver transplantation: ethics and safety.
- Pancreatitis after Liver transplantation in children: a single-center experience.
- Real-time monitoring of acute liver-alloGraft rejection using the Banff schema.
- Ribavirin dose modification based on renal function is necessary to reduce hemolysis in Liver transplant patients with hepatitis C virus infection.
- Intrahepatic Biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography.
- Posttransplant lymphoproliferative disorders in Liver transplantation: a 20-year experience.
- Steroid withdrawal under tacrolimus for primary Biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term su...
- De novo malignancies after Liver transplantation: a major cause of late death.
- Liver transplantation for Wilson's Disease: a single-center experience.
- Role of splenectomy in human Liver transplantation under modern-day immunosuppression.
- Expression of cytosolic beta-glucosidase in guinea pig Liver cells.
- Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics.
- Infectivity of hepatic alloGrafts with antibodies to hepatitis B virus.
- Single kidney transplants from donors with low estimated creatinine clearance.
- Propylthiouracil-induced hepatotoxicity.
- Early outcome of Liver transplantation in patients with a history of spontaneous bacterial peritonitis.
- Disease gravity and urgency of need as guidelines for liver allocation.
- Hepatitis B virus (HBV) re-infection following Liver transplantation: theory and practice.
- Liver transplantation for HBV-related Disease under immunosuppression with tacrolimus: an experience with 78 consecutive cases.
- Sonic hedgehog signaling in hepatocellular carcinoma: A pilot study.
Schools
Pahlavi University
Procedures Preformed
- Adrenalectomy
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Embolectomy, Thrombectomy, or Vessel Exploration
- Enterostomy (Laparoscopic or Open)
- View All
Conditions Treated
- Abdominal Pain
- Atelectasis
- Bile Duct Cancer
- Biliary Atresia
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Frontpath Health Coalition
- Golden Rule
- Medicare Advantage PFFS
- HealthSmart
- Choice Care PPO
- Kaiser Permanente
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- MVP Health Care
- NGS CoreSource
- Paramount
- POMCO Group
- Principal Life
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
- WellCare
- Wells Fargo Insurance
Awards
- CMS Meaningful Use Stage 1 Certification
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1144314618 | |
| NPPES Provider LastName | EGHTESAD | |
| NPPES Provider FirstName | BIJAN | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | General Surgery | |
| Total Claim Count | 589.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144314618 |
| Last Name Of The Provider | EGHTESAD |
| First Name Of The Provider | BIJAN |
| View All |
Similar Doctors
|
|
Dr. Kareem Abu-Elmagd, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kalman Bencsath, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexis Grucela, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey M. Marks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Dietz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Difiore, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kevin M. Parrack, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott C. Boulanger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ajai Khanna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Agripino C. Gonzales Jr., MD |
|
|
Dr. Dympna M. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse R. Gutnick, MD |